OnKure Therapeutics Inc. <OKUR.O>: Oppenheimer cuts target price to $14 from $30
OKUR•Related News
Aberdeen Intermediate Income Fund NAV stands at $14.83 as of Aug. 13
MIN•
US Physical Therapy Announces CFO
USPH•
StablecoinX Q2 FY26 net loss widens to $34.18 million; revenue rises to $62,372
USDE•
Better Home & Finance Holding Board Reviews Communications Indicating Possible Securities Law Violations By Vishal Garg
BETR•
Ultra Clean enters ATM equity distribution agreement for up to $400 million common stock sale
UCTT•